Invasive fungal infections (IFIs) demand a tremendous levy in terms
of human life and healthcare costs, despite the fact that fungal
diseases are still under-diagnosed and under reported. Several
factors such as patient characteristics, antifungal prophylaxis and
others appear to have contributed to a change in the spectrum of
invasive fungal pathogens (i.e. Candida species, Non-Candida
species, Aspergillus species and Non-Aspergillus species).
Therefore, it is important to recognize and minimize the major risk
factors associated with infection, and expanding the antifungal
drug research for new antifungal agents to treat life-threatening
invasive infections. This book would highlight past and current
research on fungal pathogens and antifungal therapies, and also
novel targets for antifungal agents for future development in
medical practice to prevent invasive fungal infections. The book
will describe novel antifungal agents, its targets, and various
development phases and potential benefits of combination therapy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!